Cholestasis has been reported as a rare presentation among patients with severe liver injury
secondary to amiodarone hepatic toxicity. We report an unusual case of amiodarone …

A 63-year-old man presented with ascites after therapy with amiodarone, 200 mg orally once
per day for 22.5 months. A liver biopsy showed grade 3 chronic hepatitis and micronodular …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

The antiarrhythmic agent amiodarone is associated with numerous adverse effects, but
clinically significant liver disease is rare. A patient is described who presented with muscle …

Amiodarone has been reported to cause asymptomatic increases in liver function tests in 15—
55% of patients. Clinically apparent, symptomatic hepatic disease occurs less frequently, but …

A72-year-old Korean male was admitted because of sudden onset of abdominal distension.
He had been treated with amiodarone 200 mg, felodipine 5 mg, hydrochlorothiazide 25 mg …

Five patients had amiodarone hepatotoxicity detected on routine biochemical monitoring.
Symptoms attributable to hepatotoxicity were minimal or absent; reversible hepatomegaly …

This analysis of the morphology of suspected amiodarone (AD) liver disease is based on a
study of liver specimens from 17 individuals. Changes similar to alcoholic liver injury were …

We report a patient with classical features of amiodarone hepatotoxicity who died of
progressive liver failure. Throughout the course of his illness, he had epigastric pain …

Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …